![](/img/cover-not-exists.png)
O.105 Early clinical results with CPG 10101, a new investigational antiviral TRL9 agonist being developed for treatment of subjects chronically infected with hepatitis C virus
J.G. McHutchison, B.R. Bacon, S.C. Gordon, E. Lawitz, M. Shiffman, N.H. Afdhal, I.M. Jacobson, A. Muir, R. Ghalib, P. Kwo, B. Freilich, H.L. Davis, A. Vicari, S. Efler, M. Al-Adhami, M.L. Morris, F. MVolume:
36
Year:
2006
Language:
english
DOI:
10.1016/s1386-6532(06)80101-0
File:
PDF, 132 KB
english, 2006